The value of NSE, S100B and MBP in evaluating the severity and prognosis in patients with subarachnoid hemorrhage
- VernacularTitle:NSE、S100B、MBP对蛛网膜下腔出血患者病情严重程度及预后的临床评估
- Author:
Haiming CONG
;
Xianglin CHI
;
Zhaorong GUO
;
Zhenguang LI
;
Li ZHOU
- Publication Type:Journal Article
- Keywords:
Phosphopyruvate hyddratase;
Subarachnoid hemorrhage;
Prognosis;
Severity of illness;
S100B;
Myelin basic protein
- From:
Chinese Journal of Postgraduates of Medicine
2008;31(25):11-13
- CountryChina
- Language:Chinese
-
Abstract:
Objective To research the significance of the levels of neuron-specific enolase(NSE), S100B and myelin basic protein(MBP) in predicting the severity and prognosis in patients with subarachnoid hemorrhage (SAH). Methods The serum levels ofNSE, SI00B and MBPwere measured within 72 hours after the injury in 36 patients with SAH(SAH group), then the severity of illness and prognosis was evaluated by world federation of neurosurgical societies(WFNS) grade and Glasgow outcome scale(GOS) respectively. Twenty healthy persons were selected as controls(control group). Results After the injury, the serum levels of NSE,SI00B and MBP in SAH group increased significantly compared with those in control group. Moreover, there were significant difference in the serum levels of NSE, S100B and MBP among different groups in different severity of illness and prognosis. Assessed the severity and prognosis by serum levels of NSE 25 μg/L, S100B 1.2 μg/L and MBP 10.0 μg/L after 72 hours of SAH, the specificity of assessing the severity by NSE, SI00B and MBP was 71.43%,61.90%, 66.67%, and the sensitivity was 73.33%,86.62% and 73.33%. At assessment of prognosis,the specificity of NSE, S100B, MBP was 69.57%, 60.87%,65.22%, and the sensitivity was 61.54%,76.92% and 69.23%. Conclusion There are higher specificity and sensitivity in evaluating the severity of illnoss and prognosis in patients with SAH by serum levels of NSE, S100B and MBP.
